Lawrence J - Search Results

1

Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.

Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, Mayers DL, Jones MC, Saldanha JM, Schmetter BS, Baxter JD. Lawrence J, et al. J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):169-78. doi: 10.1097/01.qai.0000242450.74779.ee. J Acquir Immune Defic Syndr. 2006. PMID: 16951642 Clinical Trial.

2

Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus.

Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, Crane LR, Schmetter BS, Dionne TJ, Saldanha JM, Jones MC, Baxter JD; 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS. Lawrence J, et al. N Engl J Med. 2003 Aug 28;349(9):837-46. doi: 10.1056/NEJMoa035103. N Engl J Med. 2003. PMID: 12944569 Free article. Clinical Trial.

3

Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.

Kozal MJ, Hullsiek KH, Leduc R, Novak RM, MacArthur RD, Lawrence J, Baxter JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Kozal MJ, et al. Among authors: lawrence j. Antivir Ther. 2006;11(4):457-63. Antivir Ther. 2006. PMID: 16856619 Clinical Trial.

4

Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity.

Paquet AC, Baxter J, Weidler J, Lie Y, Lawrence J, Kim R, Bates M, Coakley E, Chappey C. Paquet AC, et al. Among authors: lawrence j. PLoS One. 2011 Jan 31;6(1):e14638. doi: 10.1371/journal.pone.0014638. PLoS One. 2011. PMID: 21297946 Free PMC article.

5

A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.

Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner EM, Wu AW, Telzak EE, Lawrence J, Baxter J, Friedland G; Terry Beirn Community Program for Clinical Research on AIDS. Mannheimer S, et al. Among authors: lawrence j. AIDS Care. 2008 Feb;20(2):161-9. doi: 10.1080/09540120701534699. AIDS Care. 2008. PMID: 18293124 Clinical Trial.

6

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.

German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT. German P, et al. Among authors: lawrence j. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):424-9. doi: 10.1097/QAI.0b013e3181acb4ff. J Acquir Immune Defic Syndr. 2009. PMID: 19506482

7

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP. Pai NP, et al. Among authors: lawrence j. Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148. Cochrane Database Syst Rev. 2006. PMID: 16856117 Free PMC article. Review.

8

Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.

Pai NP, Tulsky JP, Lawrence J, Colford JM Jr, Reingold AL. Pai NP, et al. Among authors: lawrence j. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005482. doi: 10.1002/14651858.CD005482. Cochrane Database Syst Rev. 2005. PMID: 16235406 Review.

9

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.

Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB; PEARLS (ACTG A5175) Study Team. Safren SA, et al. PLoS One. 2014 Aug 25;9(8):e104178. doi: 10.1371/journal.pone.0104178. eCollection 2014. PLoS One. 2014. PMID: 25153084 Free PMC article. Clinical Trial.

10

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R; Adult AIDS Clinical Trials Group A5024 Protocol Team. Kilby JM, et al. Among authors: lawrence j. J Infect Dis. 2006 Dec 15;194(12):1672-6. doi: 10.1086/509508. Epub 2006 Nov 8. J Infect Dis. 2006. PMID: 17109338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,665 results

Search Page

Filters